Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Catecholamine clearance is not enhanced by increasing levels within the physiological range.

R D Gordon1, A W Bachmann, M Mikulecky

  • 1Endocrine-Hypertension Research Unit, Greenslopes Hospital, Brisbane, Australia.

Clinical and Experimental Hypertension. Part A, Theory and Practice
|January 1, 1989
PubMed
Summary

Rising plasma catecholamine levels, including noradrenaline (NA) and adrenaline (ADR), do not enhance their own clearance. This lack of self-regulation may contribute to hypertension development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does seasonality of births in diabetes mellitus reflect pathogenetic differences?

Bratislavske lekarske listy·2016
Same author

The Derer´s biological - cosmic week and the Halberg´s circaseptan chronome.

Bratislavske lekarske listy·2014
Same author

Concentrations of fructose in female ejaculate and urine: A comparative biochemical study.

Journal of sex research·2012
Same author

Time course of nontyphoid salmonellosis in Slovakia 1957-2008.

Bratislavske lekarske listy·2010
Same author

Circa(ultra)dians of single extrasystoles in chronic respiratory failure versus health at lowland.

Bratislavske lekarske listy·2010
Same author

Fibroblast growth factor receptor 1 is a key regulator of early adipogenic events in human preadipocytes.

American journal of physiology. Endocrinology and metabolism·2008

Area of Science:

  • Pharmacology
  • Cardiovascular Physiology
  • Endocrinology

Background:

  • Elevated plasma catecholamines, such as noradrenaline (NA) and adrenaline (ADR), are implicated in hypertension.
  • A potential protective mechanism involves enhanced clearance of catecholamines when their plasma levels rise.
  • The absence of such a mechanism could predispose individuals to hypertension.

Purpose of the Study:

  • To investigate whether rising plasma levels of noradrenaline (NA) and adrenaline (ADR) influence their own clearance rates.
  • To determine if impaired self-regulation of catecholamine clearance contributes to essential hypertension.

Main Methods:

  • Intravenous infusion of NA and ADR in normal and mild essential hypertensive subjects to achieve physiological increases in plasma levels.

Related Experiment Videos

  • Radio-enzymatic assays for plasma NA and ADR measurement.
  • Isotopic infusion technique to determine venous clearance of NA.
  • Analysis of arterial plasma level increments to assess ADR clearance.

    • Main Results:

    • Serial increases in plasma NA and ADR within the physiological range did not result in enhanced clearance.
    • A significant negative correlation was observed between plasma NA levels and NA clearance.
    • No significant effect of rising plasma levels on ADR clearance was detected.

    Conclusions:

    • The study found no evidence that rising plasma catecholamine levels enhance their own clearance in humans.
    • The observed negative correlation between NA levels and clearance suggests a potential impairment in this regulatory mechanism.
    • These findings suggest that a lack of self-limiting clearance for catecholamines might play a role in the pathophysiology of hypertension.